Bone marrow and blood plasma levels of IL-8 in aplastic anemia and their relationship with disease severity

American Journal of Hematology

Volumn 79, Issue 3, 2005, Pages 240-242

  Tripathy, Naresh Kumar ^a   Vibhuti, ^a   Nityanand, Soniya ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Aplastic anemia; Disease severity; IL 8

Indexed keywords

ALPHA CHEMOKINE; INTERLEUKIN 8;

ADULT; APLASTIC ANEMIA; ARTICLE; BLOOD LEVEL; BONE MARROW; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMATOPOIESIS; HUMAN; MALE; MYELOPOIESIS; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ANEMIA, APLASTIC; BONE MARROW; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKIN-8; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; UP-REGULATION;

EID: 22044453942     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.20367     Document Type: Article

References (10)

1. Young NS, Maciejewski J. The pathophysiology of acquired aplastic anemia. New Engl J Med 1997;336:1365-1372.
2. Majika M, Janowaska-Wieczorek A, Ratajczak J, et al. Numerous growth factors, cytokines and chemokines are secreted by human CD34 cells, myeloblasts, erythroblasts, and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner. Blood 2001;97:3075-3085.
3. Daly TJ, LaRosa GJ, Dolich J, Maione TE, Cooper S, Broxmeyer HE. High activity suppression of myeloid progenitors by chimeric mediators of IL-8 and platelet factor-4. J Biol Chem 1995;270:23282-23292.
4. Kaufman DW, Kelly JP, Levy M, Shapira S. The drug etiology of agranulocytosis and aplastic anemia. New York: Oxford University Press; 1991.
5. Camitta BM, Thomas ED, Nathan DG, et al. A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia. Blood 1971;53:504-514.
6. Bacigalupo A, Hows J, Gluckman J, et al. Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anemia (SAA): a report of EBMT SAA working party. Br J Haematol 1988;70:177-182.
7. Tang X, Zhang Y, Shao J. Detection of interleukin-8 level in peripheral blood of patients with aplastic anemia. Zhonghua Xue Ye Xue Za Zhi 1998;19:184-185.
8. Broxmeyer HE, Cooper S, Cacalano G, Hague NL, Bailish E, Moore MW. Involvement of IL-8 receptor in negative regulation of myeloid progenitor cells in vivo: evidence from mice lacking the murine IL-8 receptor homologue. J Exp Med 1996;184:1825-1823.
9. Sanchez X, Suetomi K, Cousins-Hodges B, Horton JK, Navarro J. CXC chemokine suppress proliferation of myeloid progenitor cells by activation of the CXC chemokine receptor 2. J Immunol 1998;160:906-910.
10. Larsen CG, Anderson AO, Appella E, et al. the neutrophils activating protein (NAP-1) is also chemotactic for T-lymphocytes. Science 1989;243:1464-1466.